2022年8月12日

披露:帕特爾報告接受贈款資金從拜耳,飛利浦Respironics, Respicardia Sommetrics;顧問費用從拜耳和鮑威爾曼斯菲爾德;並擔任顧問委員會和飛利浦Respironics NovaResp技術。請參閱研究對於所有其他作者的相關財務信息披露。主題添加到郵件提醒收到一封電子郵件在發布新文章時請提供您的電子郵件地址來接收電子郵件當張貼新文章。請稍後再試。如果你繼續這個問題請聯係customerservice@slackinc.com。回到Healio 3個月遠程控製和指導項目導致立即短期CPAP依從性的改善,但未能導致持續的改善隨著時間的推移,研究人員報道。”幾項研究已經證明持續行為幹預的好處,基於動機性訪談的概念發表了超過3個月沒有這樣的幹預,”桑賈伊·r·帕特爾,醫學博士,女士教授醫學、流行病學、臨床與轉化科學和睡眠中心主任和心血管結果匹茲堡大學醫療中心的研究,和他的同事在美國胸科學會上寫道。“然而,證據的優越性持續行為幹預在一個有時限的CPAP依從性是有限的。”來源:Adobe股票。 Researchers assessed real-world CPAP adherence data from 26,489 patients who initiated CPAP from July 2018 to March 2020 (mean age, 55 years; 36% women). All participants utilized a 12-month commercially available telemonitoring and coaching program (Philips Respironics). The researchers compared those received 12 months (n = 3,264) or 3 months (n = 15,424) of support with those initiated CPAP without any support (n = 7,801). Overall nightly CPAP use declined from 4.9 hours at 1 month to 4.5 hours at 3 months, 4 hours at 6 months, 3.6 hours at 12 months and 3.2 hours at 18 months. Mean CPAP use differed slightly in the first month, at 5 hours of use for patients who received 12 months of support, 4.9 hours for patients who received 3 months of CPAP and 4.8 hours for patients who did not receive support. Patients who received 3 months of support had greater CPAP use compared with patients who received no support (4.6 vs. 4.3 hours; P < .001). However, by 12 and 18 months, CPAP use declined to match that of patients who received no support. Patients who received 12 months of support had greater CPAP use compared with those who received no support at 3 months (4.6 vs. 4.3 hours; P < .001), 12 (4 vs. 3.6 hours; P < .001) and 18 months (3.3 vs. 3.2 hours; P = .02). “Future research is needed to identify the optimal duration of behavioral interventions to sustain CPAP use long-term, and randomized trials in this area are needed,” the researchers wrote. Read more about